Showing results (121-130 of 209) with videos related to
Sort By:
Pageof 21
Cell Reports|August 3, 2016
Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral SerotypeKimberly A Dowd, Christina R DeMaso, Rebecca S Pelc, et al.Journal of Virology|July 28, 2017
Mutations in the E2 Glycoprotein and the 3' Untranslated Region Enhance Chikungunya Virus Virulence in MiceDavid W Hawman, Kathryn S Carpentier, Julie M Fox, et al.Journal of Biotechnology|July 4, 2025
Characterisation of chikungunya virus neutralising monoclonal antibodies expressed in tobacco plantsCatherine M Moore, Mathew J Paul, Elizabeth Pinneh, et al.Plos Pathogens|May 3, 2013
Development of a highly protective combination monoclonal antibody therapy against Chikungunya virusPankaj Pal, Kimberly A Dowd, James D Brien, et al.NPJ Vaccines|April 20, 2023
An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infectionBrooke Bollman, Naveen Nunna, Kapil Bahl, et al.Mbio|December 5, 2019
Simian Immunodeficiency Virus Infection of Rhesus Macaques Results in Delayed Zika Virus ClearanceCarol L Vinton, Samuel J Magaziner, Kimberly A Dowd, et al.Science Immunology|February 24, 2019
Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytesJulie M Fox, Vicky Roy, Bronwyn M Gunn, et al.The Journal of Infectious Diseases|May 7, 2021
Limited Flavivirus Cross-Reactive Antibody Responses Elicited by a Zika Virus Deoxyribonucleic Acid Vaccine Candidate in HumansKatherine E Burgomaster, Bryant M Foreman, Maya A Aleshnick, et al.The Journal of Infectious Diseases|March 15, 2011
A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trialJulie E Ledgerwood, Theodore C Pierson, Sarah A Hubka, et al.Science Immunology|March 22, 2024
C1q enables influenza hemagglutinin stem binding antibodies to block viral attachment and broadens the antibody escape repertoireIvan Kosik, Jefferson Da Silva Santos, Mathew Angel, et al.Pageof 21